Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 12:45:10 UTC |
---|
Update Date | 2021-09-26 23:07:23 UTC |
---|
HMDB ID | HMDB0253857 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- |
---|
Description | ACMC-20n4qu belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. ACMC-20n4qu is a very strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). Butanoic acid, 3-((2-((3r)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3r)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(CC(O)=O)NC(=O)CN1CCCC(CCC2CCNCC2)C1=O InChI=1S/C18H31N3O4/c1-13(11-17(23)24)20-16(22)12-21-10-2-3-15(18(21)25)5-4-14-6-8-19-9-7-14/h13-15,19H,2-12H2,1H3,(H,20,22)(H,23,24) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C18H31N3O4 |
---|
Average Molecular Weight | 353.463 |
---|
Monoisotopic Molecular Weight | 353.23145649 |
---|
IUPAC Name | 3-(2-{2-oxo-3-[2-(piperidin-4-yl)ethyl]piperidin-1-yl}acetamido)butanoic acid |
---|
Traditional Name | 3-(2-{2-oxo-3-[2-(piperidin-4-yl)ethyl]piperidin-1-yl}acetamido)butanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(CC(O)=O)NC(=O)CN1CCCC(CCC2CCNCC2)C1=O |
---|
InChI Identifier | InChI=1S/C18H31N3O4/c1-13(11-17(23)24)20-16(22)12-21-10-2-3-15(18(21)25)5-4-14-6-8-19-9-7-14/h13-15,19H,2-12H2,1H3,(H,20,22)(H,23,24) |
---|
InChI Key | SFFMYDBKYYBJRY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Peptidomimetics |
---|
Sub Class | Hybrid peptides |
---|
Direct Parent | Hybrid peptides |
---|
Alternative Parents | |
---|
Substituents | - Hybrid peptide
- Beta amino acid or derivatives
- Alpha-amino acid or derivatives
- Piperidinone
- Heterocyclic fatty acid
- Delta-lactam
- Fatty acyl
- Fatty acid
- Piperidine
- Tertiary carboxylic acid amide
- Amino acid
- Secondary carboxylic acid amide
- Lactam
- Carboxamide group
- Amino acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Monocarboxylic acid or derivatives
- Secondary aliphatic amine
- Carboxylic acid
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C)N(C(=O)CN1CCCC(CCC2CCNCC2)C1=O)[Si](C)(C)C | 2973.4 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C)N(C(=O)CN1CCCC(CCC2CCNCC2)C1=O)[Si](C)(C)C | 3054.5 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C)N(C(=O)CN1CCCC(CCC2CCNCC2)C1=O)[Si](C)(C)C | 4010.6 | Standard polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #2 | CC(CC(=O)O[Si](C)(C)C)NC(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O | 3054.6 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #2 | CC(CC(=O)O[Si](C)(C)C)NC(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O | 3121.4 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #2 | CC(CC(=O)O[Si](C)(C)C)NC(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O | 4102.6 | Standard polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #3 | CC(CC(=O)O)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O)[Si](C)(C)C | 3098.9 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #3 | CC(CC(=O)O)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O)[Si](C)(C)C | 3110.3 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TMS,isomer #3 | CC(CC(=O)O)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O)[Si](C)(C)C | 4084.7 | Standard polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,3TMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O)[Si](C)(C)C | 3059.4 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,3TMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O)[Si](C)(C)C | 3185.1 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,3TMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C)CC2)C1=O)[Si](C)(C)C | 3820.2 | Standard polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN1CCCC(CCC2CCNCC2)C1=O)[Si](C)(C)C(C)(C)C | 3486.0 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN1CCCC(CCC2CCNCC2)C1=O)[Si](C)(C)C(C)(C)C | 3481.4 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN1CCCC(CCC2CCNCC2)C1=O)[Si](C)(C)C(C)(C)C | 4004.6 | Standard polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #2 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)NC(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O | 3580.5 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #2 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)NC(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O | 3543.8 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #2 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)NC(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O | 4156.1 | Standard polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #3 | CC(CC(=O)O)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O)[Si](C)(C)C(C)(C)C | 3609.6 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #3 | CC(CC(=O)O)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O)[Si](C)(C)C(C)(C)C | 3523.2 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,2TBDMS,isomer #3 | CC(CC(=O)O)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O)[Si](C)(C)C(C)(C)C | 4161.5 | Standard polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,3TBDMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O)[Si](C)(C)C(C)(C)C | 3819.6 | Semi standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,3TBDMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O)[Si](C)(C)C(C)(C)C | 3764.4 | Standard non polar | 33892256 | Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-,3TBDMS,isomer #1 | CC(CC(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN1CCCC(CCC2CCN([Si](C)(C)C(C)(C)C)CC2)C1=O)[Si](C)(C)C(C)(C)C | 3964.1 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-4191000000-65fe9cb6933a8c999a65 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)- GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 15186416 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|